Study of routine metabolism and acute toxicity of mycogenic silver nanoparticles on <i>Palaemon pandaliformis</i> (shrimp)

Ribeiro, Luiz Gustavo; Rezende, Karina Bilda de Castro; Barbieri, Edison; Souza, Ana Olı́via de

doi:10.1039/d2en00726f

Cited by 4 publications

(2 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, PVP, a non-ionic polymer that is highly soluble in water (Koczkur et al, 2015), is commonly used due to the absence of toxic effects reported in several biological systems (Zhao and Wang, 2012;Lacave et al, 2017). However, evidence shows that even if PVP is coating AgNP, these nanomaterials can promote harmful effects such as bioaccumulation in the small intestine and liver, embryo mortality, metabolism marker alterations in shrimps, reduction of fecundity in zebrafish, and tissue necrosis (Lacave et al, 2017;Orbea et al, 2017;Ribeiro et al, 2023).…”

Section: Introductionmentioning

confidence: 99%

Physiological evaluation of PVP-coated AgNP in the rat small intestine: an ex vivo approach

Chávez-Hernández,

España-Sánchez,

Aguirre-Bañuelos

et al. 2024

Front. Nanotechnol.

View full text Add to dashboard Cite

Silver nanoparticles (AgNP) are widely used globally due to their numerous properties, mainly because of their antimicrobial activity. However, the need for further regulations and legislation regarding their presence in products has led to concerns about their biosecurity, necessitating relevant biological studies at different levels. The present work aimed to evaluate the effect of the polyvinylpyrrolidone (PVP)-coated AgNP on the small intestine contraction and other mediators involved and the mediators involved (nitric oxide and serotonin) in an ex vivo model. Intestinal segments (duodenum, jejunum, and ileum) were treated in the presence and absence of five cumulative, increasing concentrations of AgNP (0.01, 0.1, 1, 10, and 100 μg/mL) and three individual concentrations of PVP-coated AgNP (0.01, 1, and 100 μg/mL), showing a transient decrease in the contractile effect in the small intestine segments treated with cumulative, increasing concentrations. This effect did not allow the isolated small intestine rings to return to their contractile basal level, and it was associated with an increase in nitric oxide (NO) production and variations in the amount of serotonin. A similar effect was observed at individual AgNP administrations but with a lesser influence on NO production. These results show that AgNP, in the function of the administration (cumulative or individual) and the segment type, can modify the contraction of the small intestine, mediated in part by NO and exerting a differential pattern in the amount of serotonin. Histological analysis revealed that specific morphological alterations induced by AgNP, such as necrosis and villi detachment, were more evident in the ileum segment. Furthermore, the accumulation of silver was observed in the small intestine villi, which could determine the physiological effects exerted upon the intestinal contraction associated with the release of a specific mediator like NO production and the presence of serotonin. These findings suggest that the small intestine is an essential target of the actions induced by AgNP, which could be ingested and reach this conduit because of the consumption of products containing these materials, modifying the intestinal motility that influences the efficiency of nutrient absorption—aspects that need to be explored and investigated in the short, medium, and long terms.

show abstract